Literature DB >> 23114835

Religiosity and exposure to users in explaining illicit drug use among emerging adults.

Joseph J Palamar1, Mathew V Kiang, Perry N Halkitis.   

Abstract

Religiosity is a protective factor against illicit drug use, but further investigation is needed to delineate which components of religiosity are protective against use. A racially diverse sample (N = 962) was surveyed about religiosity, exposure to users, and recent use of marijuana, powder cocaine, ecstasy, and nonmedical use of opioids and amphetamine. Results suggest that identifying as Agnostic increased odds of use for each of the five drugs; however, this effect disappeared when controlling for religious importance and attendance. High levels of religious attendance were protective against recent use of marijuana and cocaine, but protective effects diminished when controlling for exposure to users, which was a robust predictor of use of every drug. Religion is a protective mechanism against drug use, but this effect may diminish in light of exposure to users. Alternative preventative methods need to be directed toward individuals who are not religious or are highly exposed to users.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23114835     DOI: 10.1007/s10943-012-9660-3

Source DB:  PubMed          Journal:  J Relig Health        ISSN: 0022-4197


  24 in total

1.  Unaddressed problems in the study of spirituality and health.

Authors:  Frederick J Kier; Donna S Davenport
Journal:  Am Psychol       Date:  2004-01

2.  Religiosity and the earliest stages of adolescent drug involvement in seven countries of Latin America.

Authors:  Chuan-Yu Chen; Catherine M Dormitzer; J Bejarano; James C Anthony
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

3.  Adolescent risk behaviors and religion: findings from a national study.

Authors:  Jill W Sinha; Ram A Cnaan; Richard J Gelles
Journal:  J Adolesc       Date:  2006-05-04

4.  The dose-response relationship of adolescent religious activity and substance use: variation across demographic groups.

Authors:  Kenneth J Steinman; Amy K Ferketich; Timothy Sahr
Journal:  Health Educ Behav       Date:  2006-07-21

5.  Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents.

Authors:  Mindy A Herman-Stahl; Christopher P Krebs; Larry A Kroutil; David C Heller
Journal:  J Adolesc Health       Date:  2006-07-10       Impact factor: 5.012

6.  Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003.

Authors:  Louisa Degenhardt; Wai Tat Chiu; Nancy Sampson; Ronald C Kessler; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2007-05-03       Impact factor: 4.492

7.  Racial/ethnic differences in correlates of prescription drug misuse among young adults.

Authors:  Zaje A T Harrell; Clifford L Broman
Journal:  Drug Alcohol Depend       Date:  2009-07-18       Impact factor: 4.492

Review 8.  Researching the spiritual dimensions of alcohol and other drug problems.

Authors:  W R Miller
Journal:  Addiction       Date:  1998-07       Impact factor: 6.526

9.  Development and psychometric evaluation of scales that assess stigma associated with illicit drug users.

Authors:  Joseph J Palamar; Mathew V Kiang; Perry N Halkitis
Journal:  Subst Use Misuse       Date:  2011-07-18       Impact factor: 2.164

10.  Predictors of stigmatization towards use of various illicit drugs among emerging adults.

Authors:  Joseph J Palamar; Mathew V Kiang; Perry N Halkitis
Journal:  J Psychoactive Drugs       Date:  2012 Jul-Aug
View more
  10 in total

1.  An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States.

Authors:  Joseph J Palamar; Dimitra Kamboukos
Journal:  Subst Use Misuse       Date:  2014-06-23       Impact factor: 2.164

2.  Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions.

Authors:  Khary K Rigg; Shannon M Monnat
Journal:  Int J Drug Policy       Date:  2014-10-23

3.  Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization.

Authors:  Joseph J Palamar; Danielle C Ompad; Eva Petkova
Journal:  Int J Drug Policy       Date:  2014-02-02

4.  Demographic and socioeconomic correlates of powder cocaine and crack use among high school seniors in the United States.

Authors:  Joseph J Palamar; Danielle C Ompad
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11-05       Impact factor: 3.829

5.  Predictors of disapproval toward "hard drug" use among high school seniors in the US.

Authors:  Joseph J Palamar
Journal:  Prev Sci       Date:  2014-10

6.  Parenting styles and emerging adult drug use in Cebu, the Philippines.

Authors:  Rebecca S Hock; Michelle J Hindin; Judith K Bass; Pamela J Surkan; Catherine P Bradshaw; Tamar Mendelson
Journal:  Int J Cult Ment Health       Date:  2015-11-05

7.  The Relationship Between Spiritual Well-Being and Burnout in Collegiate Athletic Trainers.

Authors:  Leslie W Oglesby; Andrew R Gallucci; Christopher Wynveen; Kelly Ylitalo; Nicholas Benson
Journal:  J Athl Train       Date:  2021-05-01       Impact factor: 2.860

8.  Predictors of onset of cannabis and other drug use in male young adults: results from a longitudinal study.

Authors:  Severin Haug; Carla López Núñez; Julia Becker; Gerhard Gmel; Michael P Schaub
Journal:  BMC Public Health       Date:  2014-11-22       Impact factor: 3.295

9.  Belief, Behavior, and Belonging: How Faith is Indispensable in Preventing and Recovering from Substance Abuse.

Authors:  Brian J Grim; Melissa E Grim
Journal:  J Relig Health       Date:  2019-10

10.  Religious involvement and racial disparities in opioid use disorder between 2004-2005 and 2012-2013: Results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Yusuf Ransome; Angela M Haeny; Yoanna E McDowell; Ayana Jordan
Journal:  Drug Alcohol Depend       Date:  2019-10-17       Impact factor: 4.492

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.